5-1394741-C-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001044.5(SLC6A3):āc.1857G>Cā(p.Lys619Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,614,160 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001044.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC6A3 | NM_001044.5 | c.1857G>C | p.Lys619Asn | missense_variant | 15/15 | ENST00000270349.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC6A3 | ENST00000270349.12 | c.1857G>C | p.Lys619Asn | missense_variant | 15/15 | 1 | NM_001044.5 | P1 | |
SLC6A3 | ENST00000512002.2 | n.238G>C | non_coding_transcript_exon_variant | 3/3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000223 AC: 56AN: 251486Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135918
GnomAD4 exome AF: 0.000319 AC: 466AN: 1461840Hom.: 1 Cov.: 31 AF XY: 0.000292 AC XY: 212AN XY: 727218
GnomAD4 genome AF: 0.000256 AC: 39AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74472
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2022 | The c.1857G>C (p.K619N) alteration is located in exon 15 (coding exon 14) of the SLC6A3 gene. This alteration results from a G to C substitution at nucleotide position 1857, causing the lysine (K) at amino acid position 619 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 13, 2024 | Published functional studies demonstrate a damaging effect (dopamine dysfunction via a dominant-negative effect) (PMID: 34375312); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 37443770, 28749637, 34650206, 34375312, 24911152, 28719003, 26740555) - |
Parkinsonism-dystonia, infantile Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at